Prolonged RBC Storage before Transfusion Increases Extravascular Hemolysis
By LabMedica International staff writers Posted on 02 Feb 2017 |
Red blood cell transfusion, the most common procedure performed on hospitalized patients, is an indispensable component of modern medicine and establishing an adequate blood supply depends on the ability to store donated red cells safely.
Some countries have limited the maximum allowable storage duration for red cells to five weeks before transfusion, while in the USA, red blood cells can be stored for up to six weeks, but randomized trials have not assessed the effects of this final week of storage on clinical outcomes.
Scientists at the Columbia University Medical Center and their colleagues randomly assigned a group of 60 healthy volunteers to receive a unit of red blood cells that had been stored for 1, 2, 3, 4, 5, or 6 weeks. The volunteers were then monitored for 20 hours after transfusion. Chromium-51 (51Cr) post transfusion red cell recovery studies were performed and laboratory parameters measured before and at defined times after transfusion.
Routine laboratory parameters were measured and transferrin saturation and total iron binding capacity were calculated from the measured serum iron and unbound iron-binding capacity. Nontransferrin-bound iron was measured using an ultrafiltration assay and this method correlated well with other techniques. Plasma-free hemoglobin was measured by a modified cyanomethemoglobin method. Commercial enzyme-linked immunosorbent assay (ELISA) kits were used to measure Hepcidin and interleukin -6.
The authors found that extravascular hemolysis after transfusion progressively increased with increasing storage time. Longer storage duration was associated with decreasing post-transfusion red cell recovery, decreasing elevations in hematocrit, and increasing serum ferritin. After six weeks of refrigerated storage, transfusion was followed by increases in area under the curve (AUC) for serum iron, transferrin saturation, and nontransferrin-bound iron as compared with transfusion after one to five weeks of storage. Within hours after transfusion, seven of the nine volunteers who received the 6-week-old blood could not appropriately metabolize the damaged cells, thereby releasing large amounts of iron into their bloodstream.
Eldad A. Hod, MD. Assistant Professor of Pathology and senior author of the study said, “Based on the amount of iron circulating in the blood of the volunteers who received six-week-old blood, we'd predict that certain existing infections could be exacerbated. It's estimated that up to 10% to 20% of blood units used for transfusions have been stored for more than five weeks, so the number of patients who are likely to receive a unit of very old blood is substantial.” The study was published in the January 2017 issue of the Journal of Clinical Investigation.
Some countries have limited the maximum allowable storage duration for red cells to five weeks before transfusion, while in the USA, red blood cells can be stored for up to six weeks, but randomized trials have not assessed the effects of this final week of storage on clinical outcomes.
Scientists at the Columbia University Medical Center and their colleagues randomly assigned a group of 60 healthy volunteers to receive a unit of red blood cells that had been stored for 1, 2, 3, 4, 5, or 6 weeks. The volunteers were then monitored for 20 hours after transfusion. Chromium-51 (51Cr) post transfusion red cell recovery studies were performed and laboratory parameters measured before and at defined times after transfusion.
Routine laboratory parameters were measured and transferrin saturation and total iron binding capacity were calculated from the measured serum iron and unbound iron-binding capacity. Nontransferrin-bound iron was measured using an ultrafiltration assay and this method correlated well with other techniques. Plasma-free hemoglobin was measured by a modified cyanomethemoglobin method. Commercial enzyme-linked immunosorbent assay (ELISA) kits were used to measure Hepcidin and interleukin -6.
The authors found that extravascular hemolysis after transfusion progressively increased with increasing storage time. Longer storage duration was associated with decreasing post-transfusion red cell recovery, decreasing elevations in hematocrit, and increasing serum ferritin. After six weeks of refrigerated storage, transfusion was followed by increases in area under the curve (AUC) for serum iron, transferrin saturation, and nontransferrin-bound iron as compared with transfusion after one to five weeks of storage. Within hours after transfusion, seven of the nine volunteers who received the 6-week-old blood could not appropriately metabolize the damaged cells, thereby releasing large amounts of iron into their bloodstream.
Eldad A. Hod, MD. Assistant Professor of Pathology and senior author of the study said, “Based on the amount of iron circulating in the blood of the volunteers who received six-week-old blood, we'd predict that certain existing infections could be exacerbated. It's estimated that up to 10% to 20% of blood units used for transfusions have been stored for more than five weeks, so the number of patients who are likely to receive a unit of very old blood is substantial.” The study was published in the January 2017 issue of the Journal of Clinical Investigation.
Latest Hematology News
- New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
- Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
- WBC Count Could Predict Severity of COVID-19 Symptoms
- New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
- Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
- POC Hemostasis System Could Help Prevent Maternal Deaths
- New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape
- Personalized CBC Testing Could Help Diagnose Early-Stage Diseases in Healthy Individuals
- Non-Invasive Test Solution Determines Fetal RhD Status from Maternal Plasma
- First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC
- Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results
- Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
- Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
- Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere
- New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism
Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more
New Biomarkers to Improve Early Detection and Monitoring of Kidney Injury
Drug-induced kidney injury, also known as nephrotoxicity, is a prevalent issue in clinical practice, occurring when specific medications at certain doses cause damage to the kidneys. Nephrotoxicity can... Read moreImmunology
view channel
Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read moreCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read moreInnovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Each year, 11 million people across the world die of sepsis out of which 1.3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily,... Read more
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read morePathology
view channel
AI Model Predicts Patient Response to Bladder Cancer Treatment
Each year in the United States, around 81,000 new cases of bladder cancer are diagnosed, leading to approximately 17,000 deaths annually. Muscle-invasive bladder cancer (MIBC) is a severe form of bladder... Read more
New Laser-Based Method to Accelerate Cancer Diagnosis
Researchers have developed a method to improve cancer diagnostics and other diseases. Collagen, a key structural protein, plays various roles in cell activity. A novel multidisciplinary study published... Read more
New AI Model Predicts Gene Variants’ Effects on Specific Diseases
In recent years, artificial intelligence (AI) has greatly enhanced our ability to identify a vast number of genetic variants in increasingly larger populations. However, up to half of these variants are... Read more
Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read moreTechnology
view channel
Smartphones Could Diagnose Diseases Using Infrared Scans
Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more
Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more
3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis,... Read moreIndustry
view channel
Tecan Acquires ELISA Immunoassay Assets from Revvity's Cisbio Bioassays
Tecan Group (Männedorf, Switzerland) has entered into an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS (Codolet, France), a subsidiary of the... Read more